Skip to Content
Authors Bushman W
Author Profile(s)
Journal Urol. Clin. North Am. Volume: 36 Issue: 4 Pages: 403-15, v
Publish Date 2009 Nov
PubMed ID 19942041

Historically, benign prostatic hyperplasia (BPH) has been a major focus of urologic practice and surgery. But a simplistic causal relationship among prostatic enlargement, progressive obstruction, lower urinary tract symptoms, retention, and complications of retention has been challenged by recognition of the incomplete overlap of prostatic enlargement with symptoms and obstruction. The result has been a greater focus on symptoms than prostatic enlargement and a shift from surgery to medical treatment. Therefore, the question can be asked whether BPH per se, the glandular enlargement as it contributes to bladder dysfunction, or hyperplastic enlargement as a biomarker for generalized lower urinary tract dysfunction are concerns. This article addresses these issues. Copyright © 2018 The Board of Regents of the University of Wisconsin System